JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: '4 hqn'

Search results for: '4 hqn'

F1373 Anti-CTLA-4/CD152 Antibody (Tremelimumab)

Summary: Anti-CTLA-4/CD152 Antibody (Tremelimumab)
F1378 Anti-Nectin-4 Antibody (Enfortumab)

Summary: Anti-Nectin-4 Antibody (Enfortumab)
A8246 BEZ235 (NVP-BEZ235)
2 Citation

Summary: PI3K/mTOR inhibitor,ATP-competitve

insoluble in DMSO; insoluble in EtOH; insoluble in H2O
A8488 NVP-BGT226

Target: PI3K|mTOR

Summary: PI3K/mTOR inhibitor,selective and novel

insoluble in EtOH; insoluble in H2O; ≥16.28 mg/mL
A8192 Staurosporine
6 Citation

Summary: Protein kinase inhibitor, potent and cell permeable

insoluble in H2O; insoluble in EtOH; ≥11.66 mg/mL
A4005 RO4929097
1 Citation

Summary: γ secretase inhibitor

≥23.47 mg/mL
F1205 Anti-IFNg Antibody (AMG 811)

Summary: Anti-IFNg Antibody (AMG 811)
F1851 Anti-PTPRC/CD45 Antibody (Novartis patent anti-CD45)

Summary: Anti-PTPRC/CD45 Antibody (Novartis patent anti-CD45)
A5057 MGCD-265

Target: VEGFR|c-MET

Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor

≥25.9 mg/mL
A8412 Dinaciclib (SCH727965)
2 Citation

Target: Cyclin-Dependent Kinases

Summary: Potent CDK inhibitor